Johnson & Johnson's Stelara Approved by FDA for Pediatric Crohn's Disease
The FDA approved an sBLA submitted by Johnson & Johnson's Janssen Biotech for the addition of an indication for the treatment of pediatric patients 2 years and older with moderately to severely active Crohn's disease for Stelara.
